March 27, 2019
Q² Solutions Expands Genomics Capabilities in Europe
Q² Solutions Expands Genomics Capabilities in the UK, including Next Generation ...January 23, 2019
Q² Solutions and KingMed Partner to Develop In Vitro Diagnostics and Companion Diagnostics in China
Article about Q² Solutions partnering with KingMed to develop IVD products and ...August 22, 2018
Q² Solutions | EA Genomics receives New York State Clinical Laboratory Certification
Q² Solutions | EA Genomics announces that it has received a Clinical Laboratory ...August 21, 2018
Q² Solutions Welcomes Michael Brown as Immunoanalytical Scientific Director and Site Lead
Q² Solutions Welcomes Michael Brown as Immunoanalytical Scientific Director and ...July 23, 2018
Q² Solutions Expands Genomics Capabilities in China
Q² Solutions proudly announces expanded genomics capabilities in China, ...July 11, 2018
Q² Solutions Expands Bioanalytical Capabilities in China
Q² Solutions Expands Bioanalytical Capabilities in China.April 30, 2018
Q² Solutions Partners with NanoString to Market Digital Spatial Profiling Service
Q² Solutions Partners with NanoString to market Digital Spatial Profiling ...April 16, 2018
Q² Solutions | EA Genomics expands its Immuno-Oncology biomarker assay portfolio to include Tumor Mutational Burden, Microsatellite Instability and T Cell Receptor Sequencing assays
Q² Solutions expands Immuno-Oncology biomarker assay portfolio to include Tumor ...October 24, 2016
Q² Solutions Enhances Companion Diagnostics Capabilities in Collaboration with Illumina
Q² Solutions, a global clinical trials laboratory services organization, today ...June 23, 2016
